Four companies have applied to Health Canada to sell copies of Ozempic after its market exclusivity expires on Jan. 4, 2026 ...
Specifically, the likelihood that Canada’s Drug Agency would recommend that the federal government, provinces, and ...
The decision forced the Canadian units of the three cigarette makers — Imperial Tobacco Canada, JTI-Macdonald and Rothmans, Benson & Hedges (RBH) — to seek bankruptcy protection in 2019.
To fight U.S. tariffs, the Canadian government should consider suspending patent rights held by U.S. companies, including ...
Feb 19 (Reuters) - The Government of Canada has secured an initial supply of 500,000 doses of GSK's (GSK.L), opens new tab bird flu vaccine to protect individuals most at risk of being exposed to ...
Entos Pharmaceuticals Inc. is headquartered in Edmonton, Canada, with its wholly owned U.S. and U.K. subsidiaries based in San Diego, California and London, United Kingdom, respectively.
Hosted on MSN1mon
Trump says sweeping 25% tariffs start Saturday on Mexico and Canada and threatens new tax on pharmaceuticalsPresident Donald Trump said Friday afternoon that he will impose tariffs on imported goods from Mexico, Canada and China ... to impose import taxes on pharmaceuticals used by Americans, something ...
With U.S. President Donald Trump’s tariffs targeting imported pharmaceuticals, headaches lie ahead for both American patients and Canadian companies and their workers, industry experts in Canada ...
Apellis Pharmaceuticals (NASDAQ:APLS) Price Target Cut to $25.00 by Analysts at Royal Bank of Canada
Apellis Pharmaceuticals (NASDAQ:APLS – Get Free Report) had its target price cut by analysts at Royal Bank of Canada from $26.00 to $25.00 in a report issued on Monday,Benzinga reports.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results